Gripwise® Versus JAMAR®

Age-Related Sarcopenia Clinical Trial

— HANDGAGES  

Official title:

Comparison of Gripstrength Assessment Between the Gripwise® and JAMAR® Dynamometers in Elderly Inpatients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05060874
• Other study ID #: 2021-A00927-34
• Status: Completed
• Start date: September 1, 2021
• Est. completion date: November 18, 2021

Study information

• Verified date: November 2021
• Source: University Hospital, Caen
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 348
• Est. completion date: November 18, 2021
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• men and women aged 65 or over
• affiliated to a health insurance
• Francophone.

Exclusion Criteria:

• - refusal to participate
• unable to communicate
• unable to use both hands (dominant and non-dominant)

Related Conditions & MeSH terms

• Age-Related Sarcopenia
• Sarcopenia

Locations

Country	Name	City	State
France	Caen University Hospital	Caen

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Caen

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Comparison between Jamar® and Gripwise® values for grip strength measurement	Intra-class correlation between the best values obtained with each device	day1
Secondary	comparison according to the patient's position	correlations of dynamometer measurements between patients assessed in the sitting or lying position	day1
Secondary	number of attempt to reach the maximum value	Comparison of the three measurements obtained for each patient with each device	day1
Secondary	factors influencing detected weakness	significant difference in the rate of women detected as weak with a handgrip <16kg and men <27kg, between the different reasons for hospitalisation, the number of days of hospitalisation, and between the different chronic cancerous and non-cancerous pathologies (Updated Charlson Comorbidity Index), the age groups 65-79 years and =80 years	day1
Secondary	satisfaction using the devices	rate of patients finding one of both device easier to use	day1